Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 50090-4307

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500904307)

Label Image (Lbl500904307)
Label of oxybutynin chloride 10 mg extended-release tablets by A-S Medication Solutions. The label shows the NDC 50090-4307-0, product number 6881-0, storage instructions to protect from moisture and humidity at 77 degrees Fahrenheit, and packaging details of 90 extended-release tablets. The label also includes a QR code and packaging information.*
FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours. It compares oxybutynin ER 10 mg once daily (QD) with oxybutynin 5 mg three times daily (TID), featuring error bars and time points across a 24-hour period.*
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

Figure 2 (Oxybutynin Fig 2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours) up to 24 hours. Data points indicate concentration decreasing gradually from around 0.5 to 0.5 ng/mL with variability indicated by vertical error bars at each time point.*
FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

Figure 3 (Oxybutynin Fig Study 1)
A horizontal error bar chart comparing mean change in episodes per week from baseline between oxybutynin extended-release (ER) and placebo groups. The x-axis shows the mean change with standard deviation across a range from -40 to 40 episodes weekly. Both groups include error bars indicating variability.*
FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

Figure 4 (Oxybutynin Fig Study 2)
A horizontal bar chart comparing mean change (±SD) in episodes per week from baseline for oxybutynin ER and oxybutynin. The x-axis ranges from -40 to 40, showing the effects on episodes per week.*
FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

Figure 5 (Oxybutynin Fig Study 3)
A horizontal bar chart depicting mean change (±SD) in episodes per week from baseline for oxybutynin ER and oxybutynin. The x-axis indicates mean change values ranging from -40 to 40 episodes per week. Two horizontal bars represent the data for oxybutynin ER and oxybutynin, showing their respective changes from baseline.*
FDA Label Image

Chemical Structure (Oxybutynin Struc)

Chemical Structure (Oxybutynin Struc)
Chemical structure diagram of oxybutynin chloride, showing its molecular composition and key functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.